Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 7/2004

01-09-2004

Impact of Body Mass Index on the Risk of Total Cancer Incidence and Mortality Among Middle-Aged Japanese: Data from a Large-Scale Population-Based Cohort Study – The JPHC Study

Authors: Manami Inoue, Tomotaka Sobue, Shoichiro Tsugane

Published in: Cancer Causes & Control | Issue 7/2004

Login to get access
Metadata
Title
Impact of Body Mass Index on the Risk of Total Cancer Incidence and Mortality Among Middle-Aged Japanese: Data from a Large-Scale Population-Based Cohort Study – The JPHC Study
Authors
Manami Inoue
Tomotaka Sobue
Shoichiro Tsugane
Publication date
01-09-2004
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 7/2004
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/B:CACO.0000036177.77953.47

Other articles of this Issue 7/2004

Cancer Causes & Control 7/2004 Go to the issue

OriginalPaper

A Comparison of the Sources of Cancer Mortality in China

OriginalPaper

Association of the California Tobacco Control Program with Declines in Lung Cancer Incidence

OriginalPaper

Increased Risk of Developing Hepatocellular Carcinoma Associated with Carriage of the TNF2 Allele of the −308 Tumor Necrosis Factor-α Promoter Gene

OriginalPaper

Implications of Oxidative Stress and Cell Membrane Lipid Peroxidation in Human Cancer (Spain)

OriginalPaper

Association between Breast Cancer Laterality and Tumor Location, United States, 1994–1998

OriginalPaper

Attenuation of Social Class and Reproductive Risk Factor Associations for Hodgkin Lymphoma due to Selection Bias in Controls
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits